Henan Lingrui Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.66%

Henan Lingrui Pharmaceutical Co Ltd (600285) has an Asset Resilience Ratio of 5.66% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Henan Lingrui Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥325.72 Million

≈ $47.66 Million USD Cash + Short-term Investments

Total Assets

CN¥5.76 Billion

≈ $842.24 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Henan Lingrui Pharmaceutical Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Henan Lingrui Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600285 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥325.72 Million	5.66%
Total Liquid Assets	CN¥325.72 Million	5.66%

Asset Resilience Insights

Limited Liquidity: Henan Lingrui Pharmaceutical Co Ltd maintains only 5.66% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Henan Lingrui Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Henan Lingrui Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Henan Lingrui Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Henan Lingrui Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.64%	CN¥283.01 Million ≈ $41.41 Million	CN¥5.02 Billion ≈ $734.12 Million	+5.64pp
2023-12-31	0.00%	CN¥206.08K ≈ $30.16K	CN¥4.77 Billion ≈ $698.28 Million	-3.46pp
2022-12-31	3.46%	CN¥150.42 Million ≈ $22.01 Million	CN¥4.34 Billion ≈ $635.72 Million	-3.92pp
2021-12-31	7.39%	CN¥280.19 Million ≈ $41.00 Million	CN¥3.79 Billion ≈ $555.05 Million	+5.73pp
2020-12-31	1.66%	CN¥57.23 Million ≈ $8.37 Million	CN¥3.46 Billion ≈ $505.98 Million	+0.82pp
2019-12-31	0.84%	CN¥27.83 Million ≈ $4.07 Million	CN¥3.32 Billion ≈ $485.20 Million	+0.56pp
2018-12-31	0.28%	CN¥8.76 Million ≈ $1.28 Million	CN¥3.11 Billion ≈ $455.09 Million	-0.01pp
2017-12-31	0.29%	CN¥9.74 Million ≈ $1.43 Million	CN¥3.31 Billion ≈ $484.00 Million	-0.14pp
2016-12-31	0.43%	CN¥12.92 Million ≈ $1.89 Million	CN¥2.98 Billion ≈ $436.29 Million	-0.28pp
2015-12-31	0.72%	CN¥19.46 Million ≈ $2.85 Million	CN¥2.71 Billion ≈ $396.36 Million	-0.06pp
2014-12-31	0.78%	CN¥19.32 Million ≈ $2.83 Million	CN¥2.47 Billion ≈ $362.09 Million	+0.30pp
2013-12-31	0.48%	CN¥7.91 Million ≈ $1.16 Million	CN¥1.65 Billion ≈ $241.17 Million	+0.06pp
2012-12-31	0.42%	CN¥5.47 Million ≈ $800.69K	CN¥1.29 Billion ≈ $189.40 Million	-0.40pp
2011-12-31	0.83%	CN¥9.99 Million ≈ $1.46 Million	CN¥1.21 Billion ≈ $176.77 Million	-0.55pp
2010-12-31	1.38%	CN¥16.53 Million ≈ $2.42 Million	CN¥1.20 Billion ≈ $175.44 Million	+0.60pp
2009-12-31	0.78%	CN¥7.94 Million ≈ $1.16 Million	CN¥1.02 Billion ≈ $149.87 Million	-0.03pp
2008-12-31	0.80%	CN¥7.79 Million ≈ $1.14 Million	CN¥968.27 Million ≈ $141.69 Million	-1.90pp
2007-12-31	2.71%	CN¥25.52 Million ≈ $3.73 Million	CN¥942.55 Million ≈ $137.92 Million	+2.17pp
2006-12-31	0.53%	CN¥4.70 Million ≈ $687.84K	CN¥878.69 Million ≈ $128.58 Million	+0.18pp
2005-12-31	0.35%	CN¥3.06 Million ≈ $448.33K	CN¥872.24 Million ≈ $127.64 Million	+0.13pp
2004-12-31	0.22%	CN¥1.80 Million ≈ $263.75K	CN¥828.81 Million ≈ $121.28 Million	+0.08pp
2003-12-31	0.13%	CN¥1.00 Million ≈ $146.33K	CN¥741.34 Million ≈ $108.48 Million	-2.62pp
2002-12-31	2.75%	CN¥19.19 Million ≈ $2.81 Million	CN¥697.75 Million ≈ $102.10 Million	--

pp = percentage points

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.84 Billion

CN¥12.58 Billion CNY

Market Cap Rank

#6613 Global

#1523 in China

Share Price

CN¥22.19

Change (1 day)

-0.76%

52-Week Range

CN¥20.52 - CN¥24.70

All Time High

CN¥26.75